Seattle, WA, United States of America

Peter Rupert

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Peter Rupert

Introduction

Peter Rupert is an accomplished inventor based in Seattle, WA. He has made significant contributions to the field of nuclear medicine, particularly through his innovative patents. With a total of 3 patents, Rupert's work focuses on the development of chelating platforms for the delivery of radionuclides.

Latest Patents

One of Peter Rupert's latest patents involves chelating platforms designed for the delivery of radionuclides. These platforms utilize siderocalin-metal chelator combinations that bind metallic radioisotopes with high affinity. The high affinity of these combinations includes various chelator backbone arrangements with functional groups that effectively coordinate with metals. This technology can be utilized for both imaging and therapeutic purposes in nuclear medicine.

Career Highlights

Throughout his career, Peter Rupert has worked with prestigious institutions such as the Fred Hutchinson Cancer Center and the University of California. His experience in these organizations has allowed him to advance his research and contribute to significant developments in his field.

Collaborations

Peter Rupert has collaborated with notable colleagues, including Roland K Strong and Rebecca J Abergel. These partnerships have further enriched his research and innovation efforts.

Conclusion

Peter Rupert's contributions to nuclear medicine through his innovative patents highlight his expertise and dedication to advancing medical technology. His work continues to impact the field positively, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…